Lv1
58 积分 2024-10-15 加入
Activation of Wnt/β-catenin signaling promotes immune evasion via the β-catenin/IKZF1/CCL5 axis in hepatocellular carcinoma
2个月前
已完结
YAP/TAZ as master regulators in cancer: modulation, function and therapeutic approaches
4个月前
已完结
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
6个月前
已完结
Lenvatinib non-inferior to sorafenib for hepatocellular carcinoma
6个月前
已完结
Contrasting cytotoxic and regulatory T cell responses underlying distinct clinical outcomes to anti-PD-1 plus lenvatinib therapy in cancer
6个月前
已完结
皖公网安备34019202002308
